ImmersiveView software version 2.1 Product Usage: ImmersiveView is intended as pre-operative software for simulating and evaluating surgical treatment options
Reported: May 27, 2020 Initiated: April 3, 2020 #Z-2041-2020
Product Description
ImmersiveView software version 2.1 Product Usage: ImmersiveView is intended as pre-operative software for simulating and evaluating surgical treatment options
Reason for Recall
Observed an internal repetitive software glitch in ImmersiveView.
Details
- Recalling Firm
- Immersivetouch Inc
- Units Affected
- 2 units
- Distribution
- The device was distributed in the state of Illinois only.
- Location
- Chicago, IL
Frequently Asked Questions
What product was recalled? ▼
ImmersiveView software version 2.1 Product Usage: ImmersiveView is intended as pre-operative software for simulating and evaluating surgical treatment options. Recalled by Immersivetouch Inc. Units affected: 2 units.
Why was this product recalled? ▼
Observed an internal repetitive software glitch in ImmersiveView.
Which agency issued this recall? ▼
This recall was issued by the FDA Devices on May 27, 2020. Severity: Low. Recall number: Z-2041-2020.
Related Recalls
FDA Devices Moderate
Convenience Kits 1. 25GA Convenience Kit - FNX VS0644.25-FNX 2. 25GA Convenience Kit - FXX VS0644.25-FXX 3.2…
Vortex Surgical Inc. · 2026-02-11
FDA Devices Moderate
COULTER DxH Diluent, REF 628017 COULTER DxH ECO Diluent REF C67250 For use as an isotonic buffered diluent in conju…
Beckman Coulter, Inc. · 2026-02-11
FDA Devices Moderate
Product Name: Single Use 3-Lumen Sphincterotome V Model/Catalog Number: KD-V411M-1520 Product Description: These inst…
Olympus Corporation of the Americas · 2026-02-11
FDA Devices Moderate
Product Name: Disposable Triple Lumen Sphincterotome Model/Catalog Number: KD-401Q-0330 Product Description: These in…
Olympus Corporation of the Americas · 2026-02-11
FDA Devices Moderate
Product Name: Lumipulse pTau 217 Plasma Controls Model/Catalog Number: 81558 Software Version: Not Applicable Produc…
Fujirebio Diagnostics, Inc. · 2026-02-11